Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 2006-10, Vol.95 (8), p.1126-1127 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1127 |
|---|---|
| container_issue | 8 |
| container_start_page | 1126 |
| container_title | British journal of cancer |
| container_volume | 95 |
| creator | Oei, A L M Massuger, L F A G Bulten, J Ligtenberg, M J L Hoogerbrugge, N de Hullu, J A |
| description | |
| doi_str_mv | 10.1038/sj.bjc.6603409 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1147181021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-428157c878ad3c67b063f7a731d635c32e4c65f1d3c3087d886abc1bc421666b3</originalsourceid><addsrcrecordid>eNp1kUtPAyEYRYnRxPrYuibup_LoAONCY4xVkyYmprolDAMtkylUmLbpvxfTxsaFKwLfuQfIBeAKoyFGVNykdli3esgYoiNUHYEBLikpsCD8GAwQQrxAFUGn4CylNm8rJPgAbN7NstvewrFauM6pDoa1ik55mHQ0xjs_u4XzsIF9gKppokkJqtqHuMjo9PMDWuebDOVT30DXJ-i87VbGawODh_3cQGOt00pvYbAH6f0FOLGqS-Zyv56Dj_HT9PGlmLw9vz4-TApNS9YXIyJwybXgQjVUM14jRi1XnOKG0VJTYkaalRbnIc3_aYRgqta41iOCGWM1PQd3O-9yVS9Mo43vo-rkMrqFilsZlJN_J97N5SysJaEMcUKz4HoviOFrZVIv27CKPr9ZElJVlagoz9BwB-kYUorG_l6AkfwpR6ZW5nLkvpwcuNkFUgb9zMSD9Z_EN7nMlOo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229998937</pqid></control><display><type>article</type><title>Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?</title><source>Nature</source><source>Springer Nature - Complete Springer Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Oei, A L M ; Massuger, L F A G ; Bulten, J ; Ligtenberg, M J L ; Hoogerbrugge, N ; de Hullu, J A</creator><creatorcontrib>Oei, A L M ; Massuger, L F A G ; Bulten, J ; Ligtenberg, M J L ; Hoogerbrugge, N ; de Hullu, J A</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6603409</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Breast cancer ; Cancer Research ; Drug Resistance ; Epidemiology ; Hormone replacement therapy ; Letter to the Editor ; Molecular Medicine ; Mutation ; Oncology ; Ovarian cancer ; Womens health</subject><ispartof>British journal of cancer, 2006-10, Vol.95 (8), p.1126-1127</ispartof><rights>The Author(s) 2006</rights><rights>Copyright Nature Publishing Group Oct 23, 2006</rights><rights>Copyright © 2006 Cancer Research UK 2006 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c356t-428157c878ad3c67b063f7a731d635c32e4c65f1d3c3087d886abc1bc421666b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360723/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360723/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41467,42536,51298,53770,53772</link.rule.ids></links><search><creatorcontrib>Oei, A L M</creatorcontrib><creatorcontrib>Massuger, L F A G</creatorcontrib><creatorcontrib>Bulten, J</creatorcontrib><creatorcontrib>Ligtenberg, M J L</creatorcontrib><creatorcontrib>Hoogerbrugge, N</creatorcontrib><creatorcontrib>de Hullu, J A</creatorcontrib><title>Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast cancer</subject><subject>Cancer Research</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Hormone replacement therapy</subject><subject>Letter to the Editor</subject><subject>Molecular Medicine</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Ovarian cancer</subject><subject>Womens health</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUtPAyEYRYnRxPrYuibup_LoAONCY4xVkyYmprolDAMtkylUmLbpvxfTxsaFKwLfuQfIBeAKoyFGVNykdli3esgYoiNUHYEBLikpsCD8GAwQQrxAFUGn4CylNm8rJPgAbN7NstvewrFauM6pDoa1ik55mHQ0xjs_u4XzsIF9gKppokkJqtqHuMjo9PMDWuebDOVT30DXJ-i87VbGawODh_3cQGOt00pvYbAH6f0FOLGqS-Zyv56Dj_HT9PGlmLw9vz4-TApNS9YXIyJwybXgQjVUM14jRi1XnOKG0VJTYkaalRbnIc3_aYRgqta41iOCGWM1PQd3O-9yVS9Mo43vo-rkMrqFilsZlJN_J97N5SysJaEMcUKz4HoviOFrZVIv27CKPr9ZElJVlagoz9BwB-kYUorG_l6AkfwpR6ZW5nLkvpwcuNkFUgb9zMSD9Z_EN7nMlOo</recordid><startdate>20061023</startdate><enddate>20061023</enddate><creator>Oei, A L M</creator><creator>Massuger, L F A G</creator><creator>Bulten, J</creator><creator>Ligtenberg, M J L</creator><creator>Hoogerbrugge, N</creator><creator>de Hullu, J A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20061023</creationdate><title>Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?</title><author>Oei, A L M ; Massuger, L F A G ; Bulten, J ; Ligtenberg, M J L ; Hoogerbrugge, N ; de Hullu, J A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-428157c878ad3c67b063f7a731d635c32e4c65f1d3c3087d886abc1bc421666b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast cancer</topic><topic>Cancer Research</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Hormone replacement therapy</topic><topic>Letter to the Editor</topic><topic>Molecular Medicine</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Ovarian cancer</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oei, A L M</creatorcontrib><creatorcontrib>Massuger, L F A G</creatorcontrib><creatorcontrib>Bulten, J</creatorcontrib><creatorcontrib>Ligtenberg, M J L</creatorcontrib><creatorcontrib>Hoogerbrugge, N</creatorcontrib><creatorcontrib>de Hullu, J A</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oei, A L M</au><au>Massuger, L F A G</au><au>Bulten, J</au><au>Ligtenberg, M J L</au><au>Hoogerbrugge, N</au><au>de Hullu, J A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><date>2006-10-23</date><risdate>2006</risdate><volume>95</volume><issue>8</issue><spage>1126</spage><epage>1127</epage><pages>1126-1127</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/sj.bjc.6603409</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 2006-10, Vol.95 (8), p.1126-1127 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360723 |
| source | Nature; Springer Nature - Complete Springer Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Biomedical and Life Sciences Biomedicine Breast cancer Cancer Research Drug Resistance Epidemiology Hormone replacement therapy Letter to the Editor Molecular Medicine Mutation Oncology Ovarian cancer Womens health |
| title | Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A44%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply:%20Familial%20ovarian%20screening:%20how%20to%20address%20abnormal%20TVU%20findings%20and%20its%20influence%20on%20the%20efficacy%20of%20screening?&rft.jtitle=British%20journal%20of%20cancer&rft.au=Oei,%20A%20L%20M&rft.date=2006-10-23&rft.volume=95&rft.issue=8&rft.spage=1126&rft.epage=1127&rft.pages=1126-1127&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6603409&rft_dat=%3Cproquest_pubme%3E1147181021%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229998937&rft_id=info:pmid/&rfr_iscdi=true |